Home > Research > Publications & Outputs > Hypothesis

Research

Electronic data

  • med hyp manuscript

    Rights statement: This is the author’s version of a work that was accepted for publication in Medical Hypotheses. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Medical Hypotheses, 145, 2020 DOI: 10.1016/j.mehy.2020.110329

    Accepted author manuscript, 86.6 KB, PDF document

    Available under license: CC BY-NC-ND

Links

Text available via DOI:

View graph of relations

Hypothesis: Oxytocin is a direct COVID-19 antiviral

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Hypothesis: Oxytocin is a direct COVID-19 antiviral. / Diep, P.-T.; Talash, K.; Kasabri, V.
In: Medical Hypotheses, Vol. 145, 110329, 01.12.2020.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Diep, P-T, Talash, K & Kasabri, V 2020, 'Hypothesis: Oxytocin is a direct COVID-19 antiviral', Medical Hypotheses, vol. 145, 110329. https://doi.org/10.1016/j.mehy.2020.110329

APA

Diep, P-T., Talash, K., & Kasabri, V. (2020). Hypothesis: Oxytocin is a direct COVID-19 antiviral. Medical Hypotheses, 145, Article 110329. https://doi.org/10.1016/j.mehy.2020.110329

Vancouver

Diep P-T, Talash K, Kasabri V. Hypothesis: Oxytocin is a direct COVID-19 antiviral. Medical Hypotheses. 2020 Dec 1;145:110329. Epub 2020 Oct 1. doi: 10.1016/j.mehy.2020.110329

Author

Diep, P.-T. ; Talash, K. ; Kasabri, V. / Hypothesis : Oxytocin is a direct COVID-19 antiviral. In: Medical Hypotheses. 2020 ; Vol. 145.

Bibtex

@article{306415197b9c4eeca9b76181be34c681,
title = "Hypothesis: Oxytocin is a direct COVID-19 antiviral",
author = "P.-T. Diep and K. Talash and V. Kasabri",
note = "This is the author{\textquoteright}s version of a work that was accepted for publication in Medical Hypotheses. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Medical Hypotheses, 145, 2020 DOI: 10.1016/j.mehy.2020.110329",
year = "2020",
month = dec,
day = "1",
doi = "10.1016/j.mehy.2020.110329",
language = "English",
volume = "145",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",

}

RIS

TY - JOUR

T1 - Hypothesis

T2 - Oxytocin is a direct COVID-19 antiviral

AU - Diep, P.-T.

AU - Talash, K.

AU - Kasabri, V.

N1 - This is the author’s version of a work that was accepted for publication in Medical Hypotheses. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Medical Hypotheses, 145, 2020 DOI: 10.1016/j.mehy.2020.110329

PY - 2020/12/1

Y1 - 2020/12/1

U2 - 10.1016/j.mehy.2020.110329

DO - 10.1016/j.mehy.2020.110329

M3 - Journal article

VL - 145

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

M1 - 110329

ER -